Buscar
03/09/2023
Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.
Trilla-Fuertes L, Gámez-Pozo A, Prado-Vázquez G, López-Vacas R, Soriano V, Garicano F, Lecumberri MJ, Rodríguez de la Borbolla M, Majem M, Pérez-Ruiz E, González-Cao M, Oramas J, Magdaleno A, Fra J, Martín-Carnicero A, Corral M, Puértolas T, Ramos-Ruiz R, Dittmann A, Nanni P, Fresno Vara JÁ, Espinosa E. Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.. Cancers. 2023; 15(17)DOI:10.3390/cancers15174407. PMID:37686682. IF:4.500(Q1/3D).
01/09/2023
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022)
Garcia-Saenz, JA, Blancas, I, Echavarria, I, Hinojo, C, Margeli, M, Moreno, F, Pernas, S, Cajal, TRY, Ribelles, N, Bellet, M. SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). Clinical & Translational Oncology. 2023; 25(9)DOI:10.1007/s12094-023-03203-8. PMID:37148499. IF:2.800(Q2/5D).
01/09/2023
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
Sanchez-Heras, A, Cajal, TRY, Pineda, M, Aguirre, E, Grana, B, Chirivella, I, Balmana, J, Brunet, J. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022). Clinical & Translational Oncology. 2023; 25(9)DOI:10.1007/s12094-023-03202-9. PMID:37133731. IF:2.800(Q2/5D).
01/09/2023
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)
Garcia-Campelo, R, Sullivan, I, Arriola, E, Insa, A, Vidal, O, Cruz-Castellanos, P, Moran, T, Reguart, N, Zugazagoitia, J, Domine, M. SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022). Clinical & Translational Oncology. 2023; 25(9)DOI:10.1007/s12094-023-03216-3. PMID:37418123. IF:2.800(Q2/5D).